Wells Fargo & Company »

Passage Bio shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Passage Bio (PASG) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Passage Bio

Tip: Access up to 7 years of quarterly data

All positions including Passage Bio held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Passage Bio by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2026-03-31 $903 115 7.85

More positions owned by Wells Fargo & Company

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
NVIDIA Corporation Put Option (NVDA)
Ishares Tr Core S&p Ttl Stk (ITOT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds Mid Cap Etf (VO)
Amazon Put Option (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Core Msci Emkt (IEMG)

View all positions for Wells Fargo & Company

Top funds holding Passage Bio

Lynx1 Capital Management
Vestal Point Capital
Vanguard Group
Eversept Partners
Vanguard Capital Management
Renaissance Technologies
Yiheng Capital
Erste Asset Management GmbH
Ikarian Capital
Geode Capital Management
BlackRock
UBS Group
Acadian Asset Management
Boothbay Fund Management
Vanguard Fiduciary Trust

View all funds holding Passage Bio